These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 11905995)

  • 21. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
    Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
    PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with Hydrogen-Rich Saline Delays Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Zhang Y; Li H; Yang C; Fan DF; Guo DZ; Hu HJ; Meng XE; Pan SY
    Neurochem Res; 2016 Apr; 41(4):770-8. PubMed ID: 26537817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.
    Song W; Song Y; Kincaid B; Bossy B; Bossy-Wetzel E
    Neurobiol Dis; 2013 Mar; 51():72-81. PubMed ID: 22819776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
    Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
    J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1
    Bakshi R; Xu Y; Mueller KA; Chen X; Granucci E; Paganoni S; Sadri-Vakili G; Schwarzschild MA
    Mol Cell Neurosci; 2018 Oct; 92():12-16. PubMed ID: 29928993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
    J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment.
    Park JH; Jang HR; Lee IY; Oh HK; Choi EJ; Rhim H; Kang S
    Hum Mol Genet; 2017 Sep; 26(18):3615-3629. PubMed ID: 28666328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice.
    Chen L; Na R; Danae McLane K; Thompson CS; Gao J; Wang X; Ran Q
    Sci Rep; 2021 Jun; 11(1):12890. PubMed ID: 34145375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
    Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
    J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo detection of free radicals using molecular MRI and immuno-spin trapping in a mouse model for amyotrophic lateral sclerosis.
    Towner RA; Smith N; Saunders D; Lupu F; Silasi-Mansat R; West M; Ramirez DC; Gomez-Mejiba SE; Bonini MG; Mason RP; Ehrenshaft M; Hensley K
    Free Radic Biol Med; 2013 Oct; 63():351-60. PubMed ID: 23722162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Peixoto PM; Kim HJ; Sider B; Starkov A; Horvath TL; Manfredi G
    Mol Cell Neurosci; 2013 Nov; 57():104-10. PubMed ID: 24141050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
    Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
    J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention.
    Tradewell ML; Cooper LA; Minotti S; Durham HD
    Neurobiol Dis; 2011 Jun; 42(3):265-75. PubMed ID: 21296666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis.
    Rizzardini M; Lupi M; Mangolini A; Babetto E; Ubezio P; Cantoni L
    Brain Res Bull; 2006 Apr; 69(4):465-74. PubMed ID: 16624679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
    Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
    Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
    Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
    PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mouse model with impaired dynein/dynactin function develops amyotrophic lateral sclerosis (ALS)-like features in motor neurons and improves lifespan in SOD1-ALS mice.
    Teuling E; van Dis V; Wulf PS; Haasdijk ED; Akhmanova A; Hoogenraad CC; Jaarsma D
    Hum Mol Genet; 2008 Sep; 17(18):2849-62. PubMed ID: 18579581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.